Andrea Eisen

Andrea Eisen

UNVERIFIED PROFILE

Are you Andrea Eisen?   Register this Author

Register author
Andrea Eisen

Andrea Eisen

Publications by authors named "Andrea Eisen"

Are you Andrea Eisen?   Register this Author

91Publications

2390Reads

27Profile Views

Comparison of outcomes in a population-based cohort of metastatic breast cancer patients receiving anti-HER2 therapy with clinical trial outcomes.

Breast Cancer Res Treat 2020 May 31;181(1):155-165. Epub 2020 Mar 31.

Department of Medicine, University of Toronto, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-020-05614-5DOI Listing
May 2020

Cognitive markers of dementia risk in middle-aged women with bilateral salpingo-oophorectomy prior to menopause.

Neurobiol Aging 2020 Apr 29;94:1-6. Epub 2020 Apr 29.

Department of Psychology, University of Toronto, Toronto, Ontario, Canada; Rotman Research Institute, Toronto, Ontario, Canada; Tema Genus, Linköping University, Linköping, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.neurobiolaging.2020.04.019DOI Listing
April 2020

Practitioner Opinion on Contralateral Prophylactic Mastectomy: How Do We Steer a Patient-Driven Discussion?

Ann Surg Oncol 2019 Oct 11;26(11):3489-3494. Epub 2019 Jun 11.

Department of Surgery, St. Michael's Hospital, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-019-07432-6DOI Listing
October 2019

Age at first full-term birth and breast cancer risk in BRCA1 and BRCA2 mutation carriers.

Breast Cancer Res Treat 2018 Sep 17;171(2):421-426. Epub 2018 May 17.

Women's College Research Institute, Women's College Hospital, 76 Grenville St., 6th Floor, Toronto, ON, M5S 1B2, Canada.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10549-018-4822-y
Publisher Site
http://dx.doi.org/10.1007/s10549-018-4822-yDOI Listing
September 2018

Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Clinical Practice Guideline Focused Update.

J Clin Oncol 2018 08 22;36(23):2433-2443. Epub 2018 May 22.

Neelima Denduluri, The US Oncology Network, Virginia Cancer Specialists; Jamie N. Holloway, Georgetown Breast Cancer Advocates, Arlington; Mark R. Somerfield, American Society of Clinical Oncology, Alexandria, VA; Mariana Chavez-MacGregor and Sharon H. Giordano, University of Texas MD Anderson Cancer Center, Houston, TX; Melinda L. Telli, Stanford University School of Medicine, Stanford; Arti Hurria, City of Hope, Duarte, CA; Andrea Eisen and Maureen E. Trudeau, Sunnybrook Odette Cancer Centre; Andrea Eisen and Maureen E. Trudeau, Cancer Care Ontario, Toronto, Ontario, Canada; Stephanie L. Graff, Sarah Cannon Cancer Institute HCA Midwest Health, Kansas City, MO; Michael J. Hassett, Tari A. King, and Ann H. Partridge, Dana-Farber Cancer Institute; Tari A. King, Brigham & Women's Cancer Center, Boston, MA; Gary H. Lyman, Fred Hutchinson Cancer Research Center, Seattle, WA; Antonio C. Wolff, Johns Hopkins Kimmel Cancer Center, Baltimore, MD.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2018.78.8604
Publisher Site
http://dx.doi.org/10.1200/JCO.2018.78.8604DOI Listing
August 2018

Age-specific ovarian cancer risks among women with a BRCA1 or BRCA2 mutation.

Gynecol Oncol 2018 07 21;150(1):85-91. Epub 2018 May 21.

Women's College Research Institute, Women's College Hospital, Toronto, ON, Canada; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2018.05.011DOI Listing
July 2018

Serum osteoprotegerin levels and mammographic density among high-risk women.

Cancer Causes Control 2018 06 20;29(6):507-517. Epub 2018 Apr 20.

Women's College Research Institute, Women's College Hospital, 76 Grenville St., 6th Floor, Toronto, ON, M5S 1B2, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10552-018-1035-yDOI Listing
June 2018

Genetic assessment wait time indicators in the High Risk Ontario Breast Screening Program.

Mol Genet Genomic Med 2018 03 25;6(2):213-223. Epub 2018 Jan 25.

Prevention and Cancer Control, Cancer Care Ontario, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mgg3.359DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5902387PMC
March 2018

Role of Bone-Modifying Agents in Metastatic Breast Cancer: An American Society of Clinical Oncology-Cancer Care Ontario Focused Guideline Update.

J Clin Oncol 2017 Dec 16;35(35):3978-3986. Epub 2017 Oct 16.

Catherine Van Poznak, J. Sybil Biermann, and Reshma Jagsi, University of Michigan, Ann Arbor, MI; Mark R. Somerfield, American Society of Clinical Oncology, Alexandria, VA; William E. Barlow, Cancer Research and Biostatistics, Seattle, WA; Linda D. Bosserman, City of Hope, Duarte, CA; Mark J. Clemons, The Ottawa Hospital Cancer Centre, Ottawa; Sukhbinder K. Dhesy-Thind, Juravinski Hospital and Cancer Centre, Hamilton; Andrea Eisen, Theodore A. Vandenberg, London Regional Cancer Program, London, Ontario, Canada; Melissa S. Dillmon, Harbin Clinic, Rome, GA; Elizabeth S. Frank, Dana-Farber Cancer Institute; Rachel Jimenez, Beverly Moy, Massachusetts General Hospital, Boston, MA; Richard L. Theriault, MD Anderson Cancer Center, Houston, TX; and Gary C. Yee, University of Nebraska Medical Center, Omaha, NE.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.75.4614DOI Listing
December 2017

Breast screening for survivors of breast cancer: A systematic review.

Prev Med 2017 Oct 29;103:70-75. Epub 2017 Jul 29.

Prevention and Cancer Control, Cancer Care Ontario, 620 University Avenue, Toronto, Ontario M5G 2L7, Canada; Dalla Lana School of Public Health, University of Toronto, 155 College Street, 6th floor, Toronto, Ontario M5T 3M7, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ypmed.2017.07.026DOI Listing
October 2017

Reply to L. Del Mastro and A. Prat.

J Clin Oncol 2017 04 17;35(10):1139. Epub 2017 Jan 17.

Neelima Denduluri, Virginia Cancer Specialists, US Oncology Network, Arlington, VA; Mark R. Somerfield, American Society of Clinical Oncology, Alexandria, VA; Andrea Eisen, Sunnybrook Odette Cancer Centre, and Cancer Care Ontario, Toronto, Canada; Jamie N. Holloway, Arlington, VA; Arti Hurria, City of Hope, Duarte, CA; Tari A. King, Dana-Farber Cancer Institute, and Brigham & Women's Cancer Center; Boston, MA; Gary H. Lyman, Fred Hutchinson Cancer Research Center, Seattle, WA; Ann H. Partridge, Dana-Farber Cancer Institute, Boston, MA; Melinda L. Telli, Stanford University, Palo Alto, CA; Maureen E. Trudeau, Sunnybrook Health Sciences Centre, and Cancer Care Ontario, Toronto, Canada; and Antonio C. Wolff, Johns Hopkins Kimmel Cancer Center, Baltimore, MD.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2016.70.9758
Publisher Site
http://dx.doi.org/10.1200/JCO.2016.70.9758DOI Listing
April 2017

The Impact of Angelina Jolie (AJ)'s Story on Genetic Referral and Testing at an Academic Cancer Centre in Canada.

J Genet Couns 2016 12 26;25(6):1309-1316. Epub 2016 May 26.

Medical Oncology Department, Breast site, Sunnybrook Odette Cancer Centre, 2075 Bayview Avenue, Toronto, ON, M4N 3M5, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10897-016-9973-6DOI Listing
December 2016

Plasma folate, vitamin B-6, and vitamin B-12 and breast cancer risk in BRCA1- and BRCA2-mutation carriers: a prospective study.

Am J Clin Nutr 2016 Sep 27;104(3):671-7. Epub 2016 Jul 27.

Departments of Nutritional Sciences, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada; Women's College Research Institute, Women's College Hospital, Toronto, Canada;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3945/ajcn.116.133470DOI Listing
September 2016

Selection of Optimal Adjuvant Chemotherapy Regimens for Human Epidermal Growth Factor Receptor 2 (HER2) -Negative and Adjuvant Targeted Therapy for HER2-Positive Breast Cancers: An American Society of Clinical Oncology Guideline Adaptation of the Cancer Care Ontario Clinical Practice Guideline.

J Clin Oncol 2016 07 18;34(20):2416-27. Epub 2016 Apr 18.

Neelima Denduluri, US Oncology Network, Virginia Cancer Specialists, Arlington; Jamie N. Holloway, Patient Representative, Arlington; Mark R. Somerfield, American Society of Clinical Oncology, Alexandria, VA; Andrea Eisen and Maureen E. Trudeau, Sunnybrook Health Sciences Centre, and Cancer Care Ontario, Toronto, Ontario, Canada; Arti Hurria, City of Hope, Duarte; Melinda L. Telli, Stanford University, Palo Alto, CA; Tari A. King, Dana-Farber/Brigham and Women's Cancer Center; Ann H. Partridge, Dana-Farber Cancer Institute, Boston, MA; Gary H. Lyman, Fred Hutchinson Cancer Research Center, Seattle, WA; and Antonio C. Wolff, The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.67.0182DOI Listing
July 2016

Docetaxel As Monotherapy or Combined With Ramucirumab or Icrucumab in Second-Line Treatment for Locally Advanced or Metastatic Urothelial Carcinoma: An Open-Label, Three-Arm, Randomized Controlled Phase II Trial.

J Clin Oncol 2016 05 29;34(13):1500-9. Epub 2016 Feb 29.

Daniel P. Petrylak, Yale University Cancer Center, New Haven, CT; Scott T. Tagawa, Weill Cornell Medical College, New York; David Shaffer, New York Oncology Hematology, Albany, NY; Manish Kohli, Mayo Clinic, Rochester, MN; Andrea Eisen, Sunnybrook Health Sciences Centre; Srikala S. Sridhar, Princess Margaret Hospital, Toronto; Christina Canil, Ottawa Hospital Cancer Centre, Ottawa, Ontario; Kim N. Chi, British Columbia Cancer Agency, Vancouver, British Columbia, Canada; Alexander Spira, Virginia Cancer Specialists, Fairfax, VA; Alexander Spira, John M. Burke, David Shaffer, and Nicholas J. Vogelzang, US Oncology Research, The Woodlands, TX; Evan Y. Yu, University of Washington Medical Center and Fred Hutchinson Cancer Research Center, Seattle, WA; John M. Burke, Rocky Mountain Cancer Centers, Aurora, CO; Chong-Xian Pan, University of California-Davis Medical Center, Sacramento; David I. Quinn, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA; Jenny J. Kim, Johns Hopkins University, Baltimore, MD; Jeanny B. Aragon-Ching, George Washington University Medical Center, Washington, DC; Nicholas J. Vogelzang, Comprehensive Cancer Centers of Nevada, Las Vegas, NV; Shande Tang, Hui Zhang, Christopher T. Cavanaugh, Ling Gao, and John S. Kauh, Eli Lilly, Bridgewater, NJ; and Richard A. Walgren, Eli Lilly, Indianapolis, IN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.65.0218DOI Listing
May 2016

Prospective Evaluation of the 21-Gene Recurrence Score Assay for Breast Cancer Decision-Making in Ontario.

J Clin Oncol 2016 Apr 23;34(10):1065-71. Epub 2015 Nov 23.

Mark N. Levine, Jim A. Julian, and Louise Bordeleau, McMaster University, Hamilton; Mark N. Levine and Louise Bordeleau, Hamilton Health Sciences Juravinski Cancer Centre, Hamilton; Mark N. Levine and Jim A. Julian, Ontario Clinical Oncology Group and Escarpment Cancer Research Institute, Hamilton; Philippe L. Bedard, Andrea Eisen, Maureen E. Trudeau, and Kathleen I. Pritchard, University of Toronto, Toronto; Phillipe L. Bedard, Princess Margaret Hospital, Toronto; Andrea Eisen, Maureen E. Trudeau, and Kathleen I. Pritchard, Odette Sunnybrook Regional Cancer Centre; Toronto; and Brian Higgins, Peel Regional Cancer Centre, Mississauga, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.62.8503DOI Listing
April 2016

The effect of melatonin on sleep and quality of life in patients with advanced breast cancer.

Support Care Cancer 2016 Mar 11;24(3):1097-105. Epub 2015 Aug 11.

Division of Medical Oncology, Sunnybrook Odette Cancer Centre, 2075 Bayview Ave, Toronto, ON, M4N 3M5, Canada.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00520-015-2883-6
Publisher Site
http://dx.doi.org/10.1007/s00520-015-2883-6DOI Listing
March 2016

Adjuvant taxane-based chemotherapy for early stage breast cancer: a real-world comparison of chemotherapy regimens in Ontario.

Breast Cancer Res Treat 2015 Jul 31;152(1):137-145. Epub 2015 May 31.

Sunnybrook Odette Cancer Centre, Sunnybrook Health Sciences Centre, 2075 Bayview Ave., Room T2 023, T2 wing, Toronto, ON, M4N 3M5, Canada.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10549-015-3441-0
Publisher Site
http://dx.doi.org/10.1007/s10549-015-3441-0DOI Listing
July 2015

Population-based assessment of emergency room visits and hospitalizations among women receiving adjuvant chemotherapy for early breast cancer.

J Oncol Pract 2015 Mar 20;11(2):126-32. Epub 2015 Jan 20.

Trillium Health Partners-Credit Valley Hospital, Mississauga; Institute for Clinical Evaluative Sciences; Sunnybrook Odette Cancer Centre; Cancer Care Ontario; Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research, Toronto; and Ottawa Hospital Cancer Centre, Ottawa, Ontario, Canada.

View Article

Download full-text PDF

Source
http://jop.ascopubs.org/content/early/2015/01/20/JOP.2014.00
Web Search
http://jop.ascopubs.org/cgi/doi/10.1200/JOP.2014.001073
Publisher Site
http://dx.doi.org/10.1200/JOP.2014.001073DOI Listing
March 2015

Genomic testing in cancer: patient knowledge, attitudes, and expectations.

Cancer 2014 Oct 24;120(19):3066-73. Epub 2014 Jun 24.

Division of Medical Oncology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.28807DOI Listing
October 2014

Effectiveness of screening with annual magnetic resonance imaging and mammography: results of the initial screen from the ontario high risk breast screening program.

J Clin Oncol 2014 Jul 16;32(21):2224-30. Epub 2014 Jun 16.

Anna M. Chiarelli, Maegan V. Prummel, Derek Muradali, Vicky Majpruz, Meaghan Horgan, Rene S. Shumak, and Linda Rabeneck, Cancer Care Ontario; Anna M. Chiarelli, Derek Muradali, June C. Carroll, Andrea Eisen, Ellen Warner, and Linda Rabeneck, University of Toronto; June C. Carroll, Mount Sinai Hospital; Andrea Eisen and Ellen Warner, Sunnybrook Health Sciences Centre; and Wendy S. Meschino, North York General Hospital, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.52.8331DOI Listing
July 2014

Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation.

J Clin Oncol 2014 May 24;32(15):1547-53. Epub 2014 Feb 24.

Amy P.M. Finch, Barry Rosen, Andrea Eisen, Kelly A. Metcalfe, Islay Thompson, Joan Murphy, Ping Sun, and Steven A. Narod, University of Toronto; Barry Rosen and Joan Murphy, Princess Margaret Hospital; Amy P.M. Finch, Islay Thompson, Ping Sun, and Steven A. Narod, Women's College Research Institute; Andrea Eisen, Sunnybrook Odette Cancer Center, Toronto; Peter Ainsworth, London Regional Cancer Program, London, Ontario; Parviz Ghadirian, University of Montreal Hospital Centre; William D. Foulkes, McGill University, Montreal, Quebec; Charmaine Kim-Sing, British Columbia Cancer Agency, Vancouver, British Columbia, Canada; Jan Lubinski, Cezary Cybulski, and Tomasz Huzarski, Pomeranian Medical University, Szczecin, Poland; Pål Møller and Lovise Maehle, Norwegian Radium Hospital and Oslo University Hospital, Oslo, Norway; Christian F. Singer, Medical University of Vienna, Vienna, Austria; Beth Karlan, Cedars-Sinai Medical Center, Beverly Hills; Susan Neuhausen, City of Hope National Medical Center, Duarte, CA; Leigha Senter, Ohio State University Medical Center, Columbus, OH; Nadine Tung, Beth Israel Deaconess Medical Center, Boston, MA; and Henry T. Lynch, Creighton University School of Medicine, Omaha, NE.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.53.2820DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4026578PMC
May 2014

Prospective study of high-risk, BRCA1/2-mutation negative women: the 'negative study'.

BMC Cancer 2014 Mar 25;14:221. Epub 2014 Mar 25.

Familial Breast Cancer Unit, Women's College Research Institute, 790 Bay St, 7th Floor, Toronto, ON M5G 1 N8, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2407-14-221DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3973748PMC
March 2014

The impact of having a sister diagnosed with breast cancer on cancer-related distress and breast cancer risk perception.

Cancer 2013 May 7;119(9):1722-8. Epub 2013 Feb 7.

Lawrence S. Bloomberg Faculty of Nursing, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.27924
Publisher Site
http://dx.doi.org/10.1002/cncr.27924DOI Listing
May 2013

A phase II trial of sorafenib in first-line metastatic urothelial cancer: a study of the PMH Phase II Consortium.

Invest New Drugs 2011 Oct 27;29(5):1045-9. Epub 2010 Feb 27.

Princess Margaret Hospital, Phase II Consortium, 610 University Avenue, Suite 5-222, Toronto, Ontario M5G 2M9, Canada.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10637-010-9408-4
Publisher Site
http://dx.doi.org/10.1007/s10637-010-9408-4DOI Listing
October 2011

Risk of ipsilateral breast cancer in BRCA1 and BRCA2 mutation carriers.

Breast Cancer Res Treat 2011 May 9;127(1):287-96. Epub 2011 Jan 9.

Lawrence S. Bloomberg Faculty of Nursing, University of Toronto, Toronto, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-010-1336-7DOI Listing
May 2011

The symptom appraisal of breast cancer in the context of an intimate relationship.

J Health Psychol 2011 May 17;16(4):653-66. Epub 2011 Mar 17.

York University, Toronto, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1359105310386634DOI Listing
May 2011

Preferential killing of breast tumor initiating cells by N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine/tesmilifene.

Clin Cancer Res 2009 Jan;15(1):119-30

Toronto General Research Institute-University Health Network, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-08-1708DOI Listing
January 2009

Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer.

Ann Intern Med 2008 May;148(9):671-9

Sunnybrook Health Sciences Center, Odette Cancer Center, and Cancer Care Ontario. Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7326/0003-4819-148-9-200805060-00007DOI Listing
May 2008

Aromatase inhibitors in adjuvant therapy for hormone receptor positive breast cancer: a systematic review.

Cancer Treat Rev 2008 Apr 31;34(2):157-74. Epub 2007 Dec 31.

Odette Cancer Centre, Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, Toronto, ON, Canada M4N 3M5.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2007.11.001DOI Listing
April 2008

Is mammography adequate for screening women with inherited BRCA mutations and low breast density?

Cancer Epidemiol Biomarkers Prev 2008 Mar;17(3):706-11

Division of Medical Oncology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-07-0509DOI Listing
March 2008

Coffee consumption and breast cancer risk among BRCA1 and BRCA2 mutation carriers.

Int J Cancer 2006 Jan;118(1):103-7

Epidemiology Research Unit, Research Centre, Centre Hospitalier de 'Universitaire de Montréal, CHUM Hôtel-Dieu, Montréal, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.21296DOI Listing
January 2006

The risk of ovarian cancer after breast cancer in BRCA1 and BRCA2 carriers.

Gynecol Oncol 2005 Jan;96(1):222-6

Faculty of Nursing, University of Toronto, 50 St. George Street, Toronto, ON, Canada, M5S 3H4.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2004.09.039DOI Listing
January 2005

Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers.

J Clin Oncol 2004 Jun;22(12):2328-35

Centre for Research on Women' s Health, Women's College Hospital, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2004.04.033DOI Listing
June 2004

Application of breast cancer risk prediction models in clinical practice.

J Clin Oncol 2003 Feb;21(4):593-601

University of Pennsylvania Cancer Center, 14 Penn Tower, 3400 Spruce Street, Philadelphia, PA 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2003.07.007DOI Listing
February 2003

Review: breast cancer is associated with a family history of the disease in first degree relatives.

Evid Based Nurs 2002 Jul;5(3):89

Department of Medicine, McMaster University, Hamilton, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/ebn.5.3.89DOI Listing
July 2002